Broadrick Dale's Form 4 filing
BioRestorative Therapies, Inc. (BRTX) · filed Sep 14, 2023
- Accession no.
- 0001021771-23-000092
- Filed
- Sep 14, 2023
- Trade date
- Jul 28-Sep 7, 2023
- Filing delay
- 48 daysLate
- Rule 10b5-1 plan
- Not checked
This filing lists 3 non-derivative transactions and 0 derivative transactions. Open-market purchases total $5.17K. It was filed 48 days after the trade, past the 2-business-day deadline.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Broadrick DaleCIK 0001677513 | 10% Owner |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Jul 28, 2023 | Common Stock | PPurchaseAcquired | +500 | $2.89 | +$1,445 | 306,573 | Direct | |
| Sep 7, 2023 | Common Stock | PPurchaseAcquired | +1,000 | $1.81 | +$1,810 | 307,573 | Direct | |
| Sep 7, 2023 | Common Stock | PPurchaseAcquired | +1,000 | $1.91 | +$1,910 | 317,972 | Indirect |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.